MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.
about
Developments in the treatment of hemophilia B: focus on emerging gene therapyParenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury.Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunityIL-33 induces nuocytes and modulates liver injury in viral hepatitis.Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1Production of adenovirus vectors and their use as a delivery system for influenza vaccines.Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model.V(alpha)14iNKT cells promote liver pathology during adenovirus infection by inducing CCL5 production: implications for gene therapy.Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine modelGammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk.Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver.Restricting expression prolongs expression of foreign genes introduced into animals by retroviruses.Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model.Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII micePre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster modelGeneration of cell lines to complement adenovirus vectors using recombination-mediated cassette exchange.In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic miceTransient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administrationRecombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genesIncreased sensitivity to staphylococcal enterotoxin B following adenoviral infectionRelative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.Innate immune recognition of viruses and viral vectors.Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathwayGeneration of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.Adenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic bcl-2 gene.Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activationGene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy.Immunomodulation of cancer: potential use of selectively replicating agents.Gene transfer into rat brain using adenoviral vectors.TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection.A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.Current status of gene therapy for cystic fibrosis pulmonary disease.Adenovirus receptors.Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo
P2860
Q26823376-5FDEFA9E-AAFC-44FD-87DF-11C3461B4BE0Q27470502-2FC30533-89FA-4776-9D2E-B153C167CE5FQ27472836-875F1B9C-9F5D-4E50-A15E-2131A83F3C0BQ28588039-491F7BFA-B8D8-401F-8074-D5D5AAAA8939Q28743564-EDDDBD42-CEC9-4795-B488-258941CC96A1Q30226988-41177C59-537E-4447-9A82-81F4A66AA039Q30395754-9F2C7E6B-40E3-4969-84A1-C184818A7DB6Q30433085-64B79C12-25FD-4B51-8B1D-E37CCAA109FDQ30435498-73CD2165-F42B-419E-8CFC-53D8B3401492Q30439944-963357B0-0C57-42E8-966B-203F64F6C065Q32077012-6CDF4DAB-F528-41A3-93C7-C55053A0DAA8Q33603763-A7E01BC3-7C50-4293-A48F-1D470A525EE8Q33630150-936FAC83-A267-422F-9416-71FC298C5194Q33645324-F850861A-2F3B-45A0-834B-18E448BF0E88Q33645370-85FF7CFC-4630-49A5-91C6-AE3A0EEBB38DQ33713048-D4248E87-C4F2-4C94-AE20-8708A6767208Q33779555-2CA78B96-E920-4C0B-8477-9EE7A16CF98EQ33782356-ED7A2EB6-3936-4AA2-A4C0-822486064C88Q33782487-22CEA1E5-45E3-4630-887A-E045F7360E85Q33782516-8B0C21D7-519E-471A-9EA8-DF21051D428BQ33782809-5D960781-CCD3-4276-830E-5654E63D4DE4Q33782971-0971015B-8FB4-406B-A899-5C5CB2A1FF6CQ33783991-9B7904FB-3890-4CD1-9A01-48CB0750019DQ33784686-91863720-FF56-4030-8241-57EAEFF19B09Q33788137-C498013A-55F0-4E6C-A0F1-81E5EF2E3EBBQ33798736-352A0AE5-B7E6-44E3-B99A-D090DBA16225Q33805229-BD92FA31-AD5F-4622-B4A4-CCD8721380AFQ33811694-D4736329-7915-4CC9-8CA0-23DFAE224302Q33815920-F993413A-867C-4D81-B223-A5BAB7082BC6Q33818043-B36858BA-6022-44D4-AA00-8261AD224714Q33840338-8F385AAE-A17C-4EF6-9EF4-A2B80A1D5BB5Q33881920-FA29BEB5-7882-4264-893D-D5350370A091Q33882677-5A2F2AF8-E0A8-48E6-AB73-D9AC7B2CBD2BQ33904276-DF23CF95-7515-4AA5-B94B-7C0D1ACA1C17Q33904294-F3B7CDDC-26C2-4119-941E-5C7811C0A143Q33947075-CDB413C3-E23F-4004-936C-8961F2B13AE9Q33952908-991067C2-8A8B-45D4-AF1B-1B769CED9AABQ33975113-33965A93-BFE8-4B1F-9ED2-A12D29E2925BQ33984229-782D02BE-E780-4E24-A0C7-7B49F72A7EE9Q34040679-80105FE0-0D5C-422B-8B3E-C9AA013A1DEE
P2860
MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
MHC class I-restricted cytotox ...... eted recombinant adenoviruses.
@en
type
label
MHC class I-restricted cytotox ...... eted recombinant adenoviruses.
@en
prefLabel
MHC class I-restricted cytotox ...... eted recombinant adenoviruses.
@en
P1433
P1476
MHC class I-restricted cytotox ...... leted recombinant adenoviruses
@en
P304
P356
10.1016/1074-7613(94)90074-4
P407
P577
1994-08-01T00:00:00Z